Chemoinformaics analysis of 1-(4-Hydroxyphenyl)ethane-1,2-diol
Molecular Weight | 154.165 | nRot | 2 |
Heavy Atom Molecular Weight | 144.085 | nRig | 12 |
Exact Molecular Weight | 154.063 | nRing | 1 |
Solubility: LogS | -5.226 | nHRing | 0 |
Solubility: LogP | 5.813 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 22.4339 |
nHD | 3 | BPOL | 10.0321 |
QED | 0.485 |
Synth | 3.887 |
Natural Product Likeliness | 3.043 |
NR-PPAR-gamma | 0.018 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.01 |
Pgp-sub | 0 |
HIA | 0.002 |
CACO-2 | -4.452 |
MDCK | 0.0000145 |
BBB | 0.759 |
PPB | 0.945451 |
VDSS | 2.666 |
FU | 0.0530155 |
CYP1A2-inh | 0.789 |
CYP1A2-sub | 0.356 |
CYP2c19-inh | 0.475 |
CYP2c19-sub | 0.409 |
CYP2c9-inh | 0.367 |
CYP2c9-sub | 0.883 |
CYP2d6-inh | 0.132 |
CYP2d6-sub | 0.853 |
CYP3a4-inh | 0.302 |
CYP3a4-sub | 0.193 |
CL | 6.651 |
T12 | 0.123 |
hERG | 0.008 |
Ames | 0.004 |
ROA | 0.006 |
SkinSen | 0.816 |
Carcinogencity | 0.889 |
EI | 0.963 |
Respiratory | 0.015 |
NR-Aromatase | 0.018 |
Antiviral | No |
Prediction | 0.888992 |